NJK14013, a novel synthetic estrogen receptor-α agonist, exhibits estrogen receptor-independent, tumor cell-specific cytotoxicity

Author：                

Publisher： Spandidos Publications

E-ISSN： 1791-2423|47|1|280-286

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.47, Iss.1, 2015-01, pp. : 280-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth

By Tolhurst Robert  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 357-368

Springer Publishing Company

Access to resources Recommend Favorite

Opposite regulation of estrogen receptor-α and its variant ER-α36 by the Wilms' tumor suppressor WT1

By      

Oncology Letters, Vol. 2, Iss. 2, 2011-01 ,pp. : 337-341

Spandidos Publications

Access to resources Recommend Favorite

A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines

By        

International Journal of Oncology, Vol. 48, Iss. 1, 2016-01 ,pp. : 385-398

Spandidos Publications

Access to resources Recommend Favorite

Prognostic Role of Estrogen Receptor α and Estrogen Receptor  in Gastric Cancer

By Xu C.  

Annals of Surgical Oncology, Vol. 17, Iss. 9, 2010-09 ,pp. : 2503-2509

Springer Publishing Company

Access to resources Recommend Favorite

Protein kinase C-α downregulates estrogen receptor-α by suppressing c-Jun phosphorylation in estrogen receptor-positive breast cancer cells

By                    

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1423-1428

Spandidos Publications

Access to resources Recommend Favorite